---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047631"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T19:10:21.114207+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharma issues $5.74M convertible note to A.G.P. and amends Nirland note; conversion needs stockholder approval

## Summary
- Issued $5,737,500 convertible note to A.G.P. for deferred commission; 5.5% interest, matures Nov 25, 2025.
- Second Amendment to $2.65M Nirland note restricts conversion until stockholder approval; $100K/day penalty if meeting not held by Jan 9, 2025.
- Conversion price $0.10/share (adjusted for reverse splits); up to 75M shares (Nirland) and 58M shares (A.G.P.) issuable upon conversion.
- Both notes require stockholder approval under Nasdaq rules before conversion can occur.
- Company can prepay notes; customary default provisions included.

## SEC filing metadata
- accession: 0001493152-24-047631
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315224047631/0001493152-24-047631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315224047631/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047631
- JSON: https://secwatch.observer/filing/0001493152-24-047631.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047631.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.